Relative vaccine effectiveness of a CoronaVac booster dose in preventing symptomatic SARS-CoV-2 infection among healthcare workers during an Omicron period in Azerbaijan, January–August 2022

Iris Finci, Madelyn Yiseth Rojas Castro, Nabil Seyidov, Samir Mehdiyev, C. Jason McKnight, Barbara Mühlemann, Christian Drosten, Lindsey Duca, Richard Pebody, Esther Kissling, Mark A. Katz, Gahraman Hagverdiyev
doi: https://doi.org/10.1101/2023.10.20.23297300

Article usage

Article usage: October 2023 to November 2024

AbstractFullPdf
Oct 2023455988
Nov 2023761133
Dec 2023383411
Jan 202413334
Feb 202433210
Mar 20244248
Apr 202426512
May 20242044
Jun 20241625
Jul 202429312
Aug 20241528
Sep 20243459
Oct 20243076
Nov 20243047
Back to top
Posted October 25, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Relative vaccine effectiveness of a CoronaVac booster dose in preventing symptomatic SARS-CoV-2 infection among healthcare workers during an Omicron period in Azerbaijan, January–August 2022
Iris Finci, Madelyn Yiseth Rojas Castro, Nabil Seyidov, Samir Mehdiyev, C. Jason McKnight, Barbara Mühlemann, Christian Drosten, Lindsey Duca, Richard Pebody, Esther Kissling, Mark A. Katz, Gahraman Hagverdiyev
medRxiv 2023.10.20.23297300; doi: https://doi.org/10.1101/2023.10.20.23297300
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area